Minakawa, Keiji
Yokokawa, Tetsuro
Ueda, Koki
Nakajima, Osamu
Misaka, Tomofumi
Kimishima, Yusuke
Wada, Kento
Tomita, Yusuke
Miura, Saori
Sato, Yuka
Mimura, Kosaku
Sugimoto, Koichi
Nakazato, Kazuhiko
Nollet, Kenneth E.
Ogawa, Kazuei
Ikezoe, Takayuki
Hashimoto, Yuko
Takeishi, Yasuchika
Ikeda, Kazuhiko http://orcid.org/0000-0002-5269-269X
Funding for this research was provided by:
Japan Society for the Promotion of Science (15K09484, 18K08365, 15K09483, 19K17532)
Uehara Memorial Foundation (201890006)
Japanese Society of Hematology
Article History
Received: 23 December 2020
Accepted: 15 March 2021
First Online: 30 March 2021
Declarations
:
: The investigations conformed to the Guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication, 8<sup>th</sup> Edition, 2011). All efforts were addressed to minimize suffering. All studies were approved by the Animal Study Committees of Fukushima Medical University (App. No. 245, 30086) and Yamagata University (App. No. 27-153, 28-113).
: Not applicable.
: T.Y.’s and K.S.’s department receives support from Janssen Pharmaceutical K.K., Japan. T.M.’s department receives support from Fukuda Denshi Co., Ltd., Japan. These companies were not associated with the contents of this study.